LETROS Pharmaceutical

All about product
Specification
Reviews
0
Questions
0
In Stock
Product Code: EU20384
Reviews: 0
66.00€
Specifications: (See all)
Also known as
Letrozol
Blood pressure
Can cause a decrease in blood pressure
Chemical name
4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile
Dosage (medical)
2.5 mg daily
Dosage (sports)
Typically 0.5 mg to 2.5 mg daily depending on purpose and cycling needs
Specifications
Features
Also known as
Letrozol
Blood pressure
Can cause a decrease in blood pressure
Chemical name
4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile
Dosage (medical)
2.5 mg daily
Dosage (sports)
Typically 0.5 mg to 2.5 mg daily depending on purpose and cycling needs
Effects
Reduces estrogen levels, increases luteinizing hormone and follicle-stimulating hormone levels
Formula
C17H11N5
Half-life
2 days
Hepatotoxicity
Low hepatotoxicity
Lab Test
Monitoring of liver function tests, lipid profiles, and bone density
Main action
Inhibits the enzyme aromatase, preventing the synthesis of estrogen
Side effects
Hot flashes, joint pain, fatigue, increased risk of osteoporosis, nausea
Storage conditions
Store at room temperature away from moisture and heat
Substance class
Aromatase inhibitor
Trade name
Femara
Use in sports
Used by bodybuilders and athletes to reduce estrogen levels and increase testosterone levels
Water Retention
Reduces water retention
Manufacturer
Pharmaceutical
Reviews
0 / 5
average product rating
0
0
0
0
0

There are no reviews for this product, be the first to leave your review.

No questions about this product, be the first and ask your question.

LETROS Pharmaceutical
66.00€
Viewed products
TESTOSTERONE CYPIONATE HEMI PHARMA
In stock
Testosterone Suspension 50 mg GM Pharmaceuticals
In stock
TB-500 Odin Pharma 10 x 10iu Odin Pharmaceuticals
In stock
Jintropin 200 IU (USA) Europharm
In stock
Sustanonum 250 Magnum Laboratories
In stock
Pharma Test100 (Aquatest) 100 mg Pharmacom Labs
In stock
Stanozolum Magnum Laboratories
In stock
TESTOP Spectrum Pharma Spectrum Pharmaceuticals
In stock